🧐癌症患者究竟是該長期休養還是恢復工作？
42歲的蘇小姐是一位乳癌患者，在汪醫師的協助下進行高單位維他命c療法以及相關癌症輔助建議，同時也接受醫學中心的化學治療。經過1年的時間，蘇小姐整體狀況穩定，化療也告一段落，蘇小姐詢問汪醫師，她是否應該留在家裡長期休息？還是應該回到原本的職場呢？
癌症早已不是高齡者才會發生的疾病，許多青壯年人士罹患癌症時會面臨工作/職場的中斷。究竟要不要在治療後返回職場，可以先評估以下幾個問題：
1. 職場的環境與壓力如何？
如果職場常需要接觸有害物質，或是壓力極度巨大，那自然不適合做為罹癌後的復工，建議可以申請更換同公司的其他類型工作，或是降低出勤時數(例如改為兼職)，如果都無法，那就比較建議審慎評估自己身心能承受的範圍、更換其他的工作了。
2. 你喜歡你的工作嗎？
這非常的重要喔！即使是具有挑戰性或壓力，但如果是非常喜歡的工作，對於從癌症中剛打贏一場勝仗的患者來說，能夠提升自己的存在感與價值感，正向的精神力對於抗癌是相當重要的。
3. 家中是否需要你的這份薪水？
這是很現實的問題了，青壯年常常也是家中的主要經濟支柱，如果心中有過大的經濟壓力，那麼即使人在家裡休養，恐怕內心也無法平靜安穩。如果還想要多休養一段時日，那便需要評估自己/家庭的存款與開銷是否能平衡，也因此罹癌時建議也要盡早開始做財務的規劃，才能給自己更多的調整空間。
4. 自己目前的體力與心境適合返回職場嗎？
如果工作內容需要有一定的專注力才能勝任，或者是屬於一旦出錯時危害自己或他人風險較高的工作，(例如公車司機、外科醫師)那麼可能必須更為客觀地評估患者是否能夠在身心均能負荷的狀況下返回職場，而不僅僅只是考慮患者的喜惡或家中的經濟需求了。這時可能需要職場的相關同事或其他專業人士來一起協助患者做評估。
5. 如果不打算返回職場，空餘時間有打算怎麼安排呢？
如果上述條件都指向能夠返回職場，但患者還不想回到職場，那可以先自己想想打算怎麼安排生活呢？因為既然治療已經告一段落，不需要再頻繁往返醫院接受治療，多出的時間如果沒有善加管理，有時患者反而會在家中放空、看電視、胡思亂想，甚至出現退化性行為。尤其現在社群軟體過於發達，患者待在家中看到其他同齡人精彩豐富的社群文章或照片，有時會產生自己與社會脫節、無價值感的負面思考。因此如果決定不立即返回職場，但體力精神還不錯的話，應安排一些較為積極的活動，例如規律的運動、固定的才藝課程、小型的出遊等，活動可以以患者的個性與喜好來做調整。
以上便是汪醫師針對「癌症患者究竟是該長期休養還是恢復工作」給予的思考方向與建議。總的來說，當體力許可時，汪醫師是比較鼓勵癌友們回歸適合自己的職場的，工作能夠帶來成就感、價值感、人際互動、金錢收入，這些都能夠給予癌友們正向力量，對於長期抗癌的身心都能有所助益喔！祝福癌友們！
#癌症
#癌症身心
#癌症與職場
高單位維他命c癌症 在 [新聞] 高劑量維他命C 可以緩解癌症? - 看板Anti-Cancer 的推薦與評價
今天在BBC 看了底下的新聞，不過是英文的。
大致上好像是說高劑量的維他命C用靜脈注射可以有效抗癌，
但是因為好像難從專利上獲利，所以這方面研究沒那麼吸引人進入。
有人可以翻譯一下嗎? 我的英文沒很好，怕有誤解
https://www.bbc.co.uk/news/health-26038460
Vitamin C 'gives chemotherapy a boost'
By Helen Briggs
BBC News
Vitamin C:
Vitamin C has long been used as an alternative cancer therapy but evidence is
mixed
Continue reading the main story
Related Stories
Vitamins ‘effective in helping ADHD’
The problem with taking too many vitamins
High-dose vitamin C can boost the cancer-killing effect of chemotherapy in
the lab and mice, research suggests.
Given by injection, it could potentially be a safe, effective and low-cost
treatment for ovarian and other cancers, say US scientists.
Reporting in Science Translational Medicine, they call for large-scale
government clinical trials.
Pharmaceutical companies are unlikely to run trials, as vitamins cannot be
patented.
Vitamin C has long been used as an alternative therapy for cancer.
In the 1970s, chemist Linus Pauling reported that vitamin C given
intravenously was effective in treating cancer.
Continue reading the main story
“
Start Quote
Further studies are needed before we know for sure what benefits high dose
vitamin C may have for patients”
Dr Kat Arney
Cancer Research UK
However, clinical trials of vitamin C given by mouth failed to replicate the
effect, and research was abandoned.
It is now known that the human body quickly excretes vitamin C when it is
taken by mouth.
However, scientists at the University of Kansas say that when given by
injection vitamin C is absorbed into the body, and can kill cancer cells
without harming normal ones.
The researchers injected vitamin C into human ovarian cancer cells in the
lab, into mice, and into patients with advanced ovarian cancer.
They found ovarian cancer cells were sensitive to vitamin C treatment, but
normal cells were unharmed.
The treatment worked in tandem with standard chemotherapy drugs to slow
tumour growth in mouse studies. Meanwhile, a small group of patients reported
fewer side-effects when given vitamin C alongside chemotherapy.
No patent potential
Co-researcher Dr Jeanne Drisko said there was growing interest in the use of
vitamin C by oncologists.
"Patients are looking for safe and low-cost choices in their management of
cancer," she told BBC News. "Intravenous vitamin C has that potential based
on our basic science research and early clinical data."
One potential hurdle is that pharmaceutical companies are unlikely to fund
trials of intravenous vitamin C because there is no ability to patent natural
products.
"Because vitamin C has no patent potential, its development will not be
supported by pharmaceutical companies," said lead researcher Qi Chen.
"We believe that the time has arrived for research agencies to vigorously
support thoughtful and meticulous clinical trials with intravenous vitamin C."
Dr Kat Arney, science communications manager for Cancer Research UK, said
there was a long history of research into vitamin C for treating cancer.
"It's difficult to tell with such a small trial - just 22 patients - whether
high-dose vitamin C injections had any effect on survival, but it's
interesting that it seemed to reduce the side-effects of chemotherapy," she
said.
"Any potential treatment for cancer needs to be thoroughly evaluated in large
clinical trials to make sure it's safe and effective, so further studies are
needed before we know for sure what benefits high dose vitamin C may have for
patients."
--
※ 發信站: 批踢踢實業坊(ptt.cc)
◆ From: 36.237.85.35
※ 編輯: sun8 來自: 211.75.95.94 (02/11 09:40)
... <看更多>